Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kurtz KG"'
Autor:
Bourne CM; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Wallisch P; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Dacek MM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Gardner TJ; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Pierre S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Vogt K; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York., Corless BC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Bah MA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Romero-Pichardo JE; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Charles A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Kurtz KG; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Tan DS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York.; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York., Scheinberg DA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 Sep 01; Vol. 11 (9), pp. 1253-1265.
Autor:
Bourne CM; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065., Wallisch P; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10021., Dacek M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10021., Gardner T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065., Pierre S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Vogt K; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10065., Corless BC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10021., Bah MA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065., Romero Pichardo J; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Charles A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065., Kurtz KG; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10021., Tan DS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10065.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10065., Scheinberg DA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.; Pharmacology Program, Weill Cornell Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10021.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10065.; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 May 01. Date of Electronic Publication: 2023 May 01.
Autor:
Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY., Kurtz KG; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY., Wallisch P; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY., Pierre SA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Tri-institutunal MD-PhD Program, Weill Cornell Medicine, New York, NY., Khayat S; Pharmacology Program, Weill Cornell Medicine, New York, NY.; Immunology Program, Sloan Kettering Institute, New York, NY., Bourne CM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Medicine, New York, NY., Gardner TJ; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Vogt KC; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, The Rockefeller University, New York, NY., Aquino N; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY., Younes A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood [Blood] 2023 Apr 20; Vol. 141 (16), pp. 2003-2015.
Autor:
Gardner TJ; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee JP; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bourne CM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wijewarnasuriya D; Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; BCMB Allied Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kinarivala N; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kurtz KG; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Corless BC; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chang AY; BCMB Allied Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mo G; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nguyen KM; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brentjens RJ; Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tan DS; Chemical Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org.; Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. tand@mskcc.org., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.; Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scheinbd@mskcc.org.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2022 Feb; Vol. 18 (2), pp. 216-225. Date of Electronic Publication: 2021 Dec 30.